Cargando…
Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255747/ https://www.ncbi.nlm.nih.gov/pubmed/34248550 http://dx.doi.org/10.1159/000515782 |
_version_ | 1783717972003520512 |
---|---|
author | Shwaylia, Hawraa Ali, Elrazi Yassin, Mohamed A. |
author_facet | Shwaylia, Hawraa Ali, Elrazi Yassin, Mohamed A. |
author_sort | Shwaylia, Hawraa |
collection | PubMed |
description | Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F). |
format | Online Article Text |
id | pubmed-8255747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-82557472021-07-09 Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) Shwaylia, Hawraa Ali, Elrazi Yassin, Mohamed A. Case Rep Oncol Case Report Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F). S. Karger AG 2021-06-11 /pmc/articles/PMC8255747/ /pubmed/34248550 http://dx.doi.org/10.1159/000515782 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Shwaylia, Hawraa Ali, Elrazi Yassin, Mohamed A. Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_full | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_fullStr | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_full_unstemmed | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_short | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_sort | interferon-alpha 2-a and its dual effect in treating two diseases (hepatitis c and polycythemia vera) |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255747/ https://www.ncbi.nlm.nih.gov/pubmed/34248550 http://dx.doi.org/10.1159/000515782 |
work_keys_str_mv | AT shwayliahawraa interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera AT alielrazi interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera AT yassinmohameda interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera |